Conference abstract · 30 Jul 2017
Conference abstractPublished 14 Sep 2015
Nonthermal Plasma-Treated solutions as Antimicrobial Agents in Control of Multi-Drug Resistant Pathogens
Drexel University College of Medicine, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Multi-drug resistance in bacterial pathogens (MDRO) is a significant challenge that healthcare facilities faces globally. Surface-associated biofilms often act as reservior of MDRO and a source of dissemination of resistance. MDRO in biofilm form requires much higher doses of antimicrobial biocides than their planktonic counterpart. Such doses are often cytotoxic, and can not be repeatedly used. Additionally, an increase in resistant phenotypes due to spontaneous mutations challenges traditional antibiotics and other antimicrobial agents. Nonthermal plasma treatments are increasingly used in disinfection and sterilization, in different forms of applications, such as direct plasma application over the surface or first treating the liquid of interest, and then applying it over surface (animate or inanimate). Aqueous solutions treated by plasma at atmosphere air contains a complex cocktail of reactive species such as hydrogen peroxide, superoxide, nitric oxide, nitrogen dioxide, nitrite and nitrate, and typically have a low pH (which helps in stabilizing some of these species). All these species are physiologically reactive and known to kill bacteria in suspension by exerting a synergistic antimicrobial effect. Recently, we demonstrated that nonthermal plasma (plasma) -treated solutions acquire strong stable antimicrobial activity, and these solutions have a rapid and broad spectrum activity against multidrug resistant bacterial pathogens. This activity is retained for at least two years at room temperature, and the solution(s) exhibit appreciable toxicity. The proposed research presents the understanding of the mechanisms underlying the bactericidal effect of one of the plasma-activated antimicrobial solution, using E. coli’s physiological responses as the probe
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 12 Oct 2020
ISOLATION OF MULTI-DRUG RESISTANT POTENTIAL PATHOGENIC BACTERIA FROMBLOWFLIES (Calliphoraspp.) COLLECTED FROM DIFFERENT AREAS OF DHAKACITY
Conference abstract · 14 Jun 2018
Overcoming antibiotic resistance: Inhibition of ld-transpeptidation in multi-drug resistant pathogens
Research article · 12 Oct 2017
Prevalence of multi-drug resistant pathogen isolated from high vaginal swab in Nigeria.
Conference abstract · 20 Oct 2016
Synergistic antimicrobial therapy using nanoparticles and antibiotics for the treatment of multi-drug resistant bacteria
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectInfectious Diseases
- SubjectMicrobiology
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Suresh G. Joshi”
